EA201100750A1 - Замещенные диоксопиперидинилфталимидные производные - Google Patents
Замещенные диоксопиперидинилфталимидные производныеInfo
- Publication number
- EA201100750A1 EA201100750A1 EA201100750A EA201100750A EA201100750A1 EA 201100750 A1 EA201100750 A1 EA 201100750A1 EA 201100750 A EA201100750 A EA 201100750A EA 201100750 A EA201100750 A EA 201100750A EA 201100750 A1 EA201100750 A1 EA 201100750A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- phthalimide derivatives
- substituted
- dioxopiperidinyl
- derivatives
- substituted dioxopiperidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Данное изобретение относится к новым замещенным диоксопиперидинилфталимидным производным и их фармацевтически приемлемым кислотно-аддитивным солям. Изобретение также обеспечивает композиции, содержащие соединение согласно настоящему изобретению, и применение таких композиций для лечения заболеваний и состояний, благоприятно подвергаемых лечению иммуномодуляторным агентом.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11498908P | 2008-11-14 | 2008-11-14 | |
PCT/US2009/006105 WO2010056344A1 (en) | 2008-11-14 | 2009-11-13 | Substituted dioxopiperidinyl phthalimide derivaties |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201100750A1 true EA201100750A1 (ru) | 2011-12-30 |
EA020117B1 EA020117B1 (ru) | 2014-08-29 |
Family
ID=42170217
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201391720A EA201391720A1 (ru) | 2008-11-14 | 2009-11-13 | Замещенные диоксопиперидинилфталимидные производные |
EA201100750A EA020117B1 (ru) | 2008-11-14 | 2009-11-13 | Замещенные диоксопиперидинилфталимидные производные |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201391720A EA201391720A1 (ru) | 2008-11-14 | 2009-11-13 | Замещенные диоксопиперидинилфталимидные производные |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2373165B1 (ru) |
JP (1) | JP5647615B2 (ru) |
KR (1) | KR101649332B1 (ru) |
CN (1) | CN102245023B (ru) |
AU (1) | AU2009314568B2 (ru) |
BR (1) | BRPI0915267A2 (ru) |
CA (1) | CA2743902C (ru) |
EA (2) | EA201391720A1 (ru) |
ES (1) | ES2444433T3 (ru) |
MX (1) | MX2011005112A (ru) |
WO (1) | WO2010056344A1 (ru) |
ZA (1) | ZA201104361B (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2616976C1 (ru) * | 2016-04-07 | 2017-04-19 | Олег Ростиславович Михайлов | Кристаллическая β-модификация 3-(4-амино-1-оксо-1,3-дигидро-2Н-изоиндол-2-ил)-пиперидин-2,6-диона, способ её получения и фармацевтическая композиция на её основе |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288414B2 (en) | 2007-09-12 | 2012-10-16 | Deuteria Pharmaceuticals, Inc. | Deuterium-enriched lenalidomide |
US9045453B2 (en) * | 2008-11-14 | 2015-06-02 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
MX2013005434A (es) * | 2010-11-18 | 2013-09-26 | Deuteria Pharmaceuticals Inc | 3´ - deutero - polidomida. |
WO2012079075A1 (en) | 2010-12-10 | 2012-06-14 | Concert Pharmaceuticals, Inc. | Deuterated phthalimide derivatives |
WO2012079022A1 (en) * | 2010-12-10 | 2012-06-14 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
CA2867134C (en) * | 2011-03-28 | 2019-05-07 | Sheila Dewitt | 2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds |
WO2012177678A2 (en) * | 2011-06-22 | 2012-12-27 | Celgene Corporation | Isotopologues of pomalidomide |
WO2013130849A1 (en) | 2012-02-29 | 2013-09-06 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
US9643950B2 (en) * | 2012-10-22 | 2017-05-09 | Concert Pharmaceuticals, Inc. | Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione} |
WO2014110322A2 (en) * | 2013-01-11 | 2014-07-17 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
AU2014205043B2 (en) * | 2013-01-14 | 2018-10-04 | Deuterx, Llc | 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives |
US9290475B2 (en) | 2013-03-14 | 2016-03-22 | Deuterx, Llc | 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same |
LV14985B (lv) | 2013-10-14 | 2015-06-20 | Latvijas Organiskās Sintēzes Institūts | Lenalidomīda iegūšanas process |
JP6616934B2 (ja) * | 2014-05-22 | 2019-12-04 | 株式会社 資生堂 | レナリドミドの光学分割方法 |
EP3708168A3 (en) * | 2014-09-14 | 2020-12-09 | Avanir Pharmaceuticals, Inc. | Combinations of deuterated dextromethorphan and quinidine for the treatment of agitation in dementia |
PL3214081T3 (pl) | 2014-10-30 | 2021-04-06 | Kangpu Biopharmaceuticals, Ltd. | Pochodna izoindoliny, półprodukt, sposób wytwarzania, kompozycja farmaceutyczna i ich zastosowanie |
US9809603B1 (en) | 2015-08-18 | 2017-11-07 | Deuterx, Llc | Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same |
CA3046869C (en) | 2016-12-16 | 2022-05-17 | Kangpu Biopharmaceuticals, Ltd. | Combination of a benzoheterocyclic compound and an androgen receptor pathway modulator for the treatment of prostate cancer |
US20210317109A1 (en) * | 2018-09-07 | 2021-10-14 | Medshine Discovery Inc. | Tricyclic substituted piperidine dione compound |
JP7209897B2 (ja) * | 2019-09-12 | 2023-01-20 | メッドシャイン ディスカバリー インコーポレイテッド | Crbnタンパク質モジュレーターとしての二環式化合物 |
JP2023517393A (ja) * | 2020-03-17 | 2023-04-25 | メッドシャイン ディスカバリー インコーポレイテッド | タンパク質分解調整剤およびその使用方法 |
CN115850686A (zh) * | 2021-09-27 | 2023-03-28 | 广州谷森制药有限公司 | 新型氘代peg脂质化合物、其制备方法、组合物和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6281230B1 (en) * | 1996-07-24 | 2001-08-28 | Celgene Corporation | Isoindolines, method of use, and pharmaceutical compositions |
CA2261762C (en) * | 1996-07-24 | 2008-06-17 | Celgene Corporation | Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
US7091353B2 (en) * | 2000-12-27 | 2006-08-15 | Celgene Corporation | Isoindole-imide compounds, compositions, and uses thereof |
JP2007517007A (ja) * | 2003-12-24 | 2007-06-28 | アストラゼネカ アクチボラグ | Tie2(TEK)活性を持つピリミジン |
EP1853302A2 (en) * | 2005-02-18 | 2007-11-14 | Novartis Vaccines and Diagnostics, Inc. | Antiangiogenic agents with aldesleukin |
JP5301991B2 (ja) * | 2005-07-29 | 2013-09-25 | コンサート ファーマシューティカルズ インコーポレイテッド | 新規なベンゾ[d][1,3]−ジオキソール誘導体 |
WO2008099794A1 (en) * | 2007-02-09 | 2008-08-21 | Takeda Pharmaceutical Company Limited | Fused ring compounds as partial agonists of ppar-gamma |
US8288414B2 (en) * | 2007-09-12 | 2012-10-16 | Deuteria Pharmaceuticals, Inc. | Deuterium-enriched lenalidomide |
US9045453B2 (en) * | 2008-11-14 | 2015-06-02 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
-
2009
- 2009-11-13 ES ES09826438.5T patent/ES2444433T3/es active Active
- 2009-11-13 KR KR1020117013575A patent/KR101649332B1/ko active IP Right Grant
- 2009-11-13 CA CA2743902A patent/CA2743902C/en not_active Expired - Fee Related
- 2009-11-13 MX MX2011005112A patent/MX2011005112A/es active IP Right Grant
- 2009-11-13 BR BRPI0915267-9A patent/BRPI0915267A2/pt not_active Application Discontinuation
- 2009-11-13 WO PCT/US2009/006105 patent/WO2010056344A1/en active Application Filing
- 2009-11-13 AU AU2009314568A patent/AU2009314568B2/en not_active Ceased
- 2009-11-13 EA EA201391720A patent/EA201391720A1/ru unknown
- 2009-11-13 EA EA201100750A patent/EA020117B1/ru not_active IP Right Cessation
- 2009-11-13 CN CN200980150592.2A patent/CN102245023B/zh not_active Expired - Fee Related
- 2009-11-13 EP EP09826438.5A patent/EP2373165B1/en active Active
- 2009-11-13 JP JP2011536328A patent/JP5647615B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-10 ZA ZA2011/04361A patent/ZA201104361B/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2616976C1 (ru) * | 2016-04-07 | 2017-04-19 | Олег Ростиславович Михайлов | Кристаллическая β-модификация 3-(4-амино-1-оксо-1,3-дигидро-2Н-изоиндол-2-ил)-пиперидин-2,6-диона, способ её получения и фармацевтическая композиция на её основе |
Also Published As
Publication number | Publication date |
---|---|
EA020117B1 (ru) | 2014-08-29 |
EA201391720A1 (ru) | 2014-04-30 |
EP2373165A1 (en) | 2011-10-12 |
ES2444433T3 (es) | 2014-02-25 |
WO2010056344A1 (en) | 2010-05-20 |
KR101649332B1 (ko) | 2016-08-18 |
CA2743902C (en) | 2016-09-20 |
CN102245023B (zh) | 2015-05-13 |
BRPI0915267A2 (pt) | 2015-08-18 |
EP2373165A4 (en) | 2012-06-20 |
AU2009314568B2 (en) | 2016-01-21 |
JP5647615B2 (ja) | 2015-01-07 |
ZA201104361B (en) | 2014-11-26 |
MX2011005112A (es) | 2011-06-16 |
KR20110086731A (ko) | 2011-07-29 |
JP2012508738A (ja) | 2012-04-12 |
AU2009314568A1 (en) | 2010-05-20 |
EP2373165B1 (en) | 2013-10-30 |
CA2743902A1 (en) | 2010-05-20 |
CN102245023A (zh) | 2011-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
EA201100503A1 (ru) | Глюкозидные производные и их применения | |
EA201290191A1 (ru) | N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ | |
EA201101583A1 (ru) | Ингибиторы pi3 киназы или mtor | |
EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
ATE517882T1 (de) | Chinolinderivate | |
GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
EA201290980A1 (ru) | Производные 1-амино-2-циклопропилэтилбороновой кислоты | |
UA109667C2 (xx) | Похідні хіназолін-4(3h)-ону, що використовуються як інгібітори pi3-кінази | |
EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
EA201300684A1 (ru) | Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1 | |
EA201290183A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
UA108743C2 (uk) | Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази | |
EA201290416A1 (ru) | Новые спиропиперидиновые соединения | |
EA201270043A1 (ru) | Замещенные производные изоиндолин-1,3-диона | |
EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
EA201071329A1 (ru) | Диамидные производные адамантана и их применение | |
EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
EA201001196A1 (ru) | Соединения 4-пиридинона и их применение для лечения рака | |
EA201170722A1 (ru) | Лактамы в качестве ингибиторов бета-секретазы | |
EA201101533A1 (ru) | Гетероциклические соединения в качестве ингибиторов mek | |
EA200801996A1 (ru) | 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |